Alembic Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has issued a Postal Ballot Notice for two special business items to be passed by shareholders through remote e-voting between 2nd March 2026 and 31st March 2026. The first item is the appointment of Mr. Rajkumar Baheti (DIN: 00332079), currently an Executive Director, as a Non-Executive Non-Independent Director with effect from 1st April 2026, following the completion of his executive tenure on 31st March 2026. The second item seeks approval for payment of professional fees of up to Rs. 2.5 Crores per annum to Mr. Baheti for a 1-year professional engagement covering strategic advisory, legacy matters and management succession support. Mr. Baheti, aged 66, is a Chartered Accountant and Company Secretary with over 45 years of experience and has been on the Board since June 2010; his last drawn remuneration in FY25-26 was Rs. 5.35 Crores. The transaction represents about 0.04% of the company's annual consolidated turnover and has been approved by the Audit Committee and the Nomination and Remuneration Committee.
This is a routine management transition with no material impact on shareholders — Mr. Baheti is shifting from executive to non-executive role while continuing advisory support. The professional fee of Rs. 2.5 Crore per annum is a related-party transaction requiring shareholder approval, but represents a small fraction of company turnover, suggesting limited financial impact and no expected stock price movement.